Judge Gives Final Approval To $7.75M Settlement In Stock-Drop Class Action

( March 3, 2026, 1:23 PM EST) -- NEW YORK — A federal judge in New York granted final approval to a $7.75 million settlement in a class action brought by investors against a biopharmaceutical company and certain of its current and former executives that alleged that the defendants made false and misleading statements that caused the company’s stock price to drop and investors to lose money....